All News

Acquisition will extend UBC's services to include an affordability solution.

ESG Evaluation names Sanofi as one of the most sustainability-committed companies.

Obstacles in data exchange remain for industry.

Partnership will utilize Medable's trial software platform to enhance access.

COVID-19 response, global workforce both among highlights.

Monoclonal antibody manufacturing site will help deliver innovative medicines to patients around the world.

Scientific vacancies in the UK are up 58% in 2021 compared to 2020, says report.

Funding brings total investment to $123 million.

Indegene’s 2021–22 survey on the digital habits of HCPs across major regions provides some answers to pharma marketers looking to boost their post-pandemic physician engagement campaigns.

In a highly unusual decision for a therapy approved by FDA, CMS has taken action to limit prescribing and use of Biogen’s new and controversial Alzheimer’s treatment Aduhelm.

As big tech’s healthcare disruption efforts flag, biopharma can step up to empower patients and improve care, writes Rohit Gupta.

Indegene’s Kay Uttech won the “Engagement Achievement Award” by the Healthcare Businesswomen’s Association (HBA) for her contribution for promoting gender parity in the industry in 2021. 

Sameer Rabbani talks to Pharm Exec about the new initiative from GSK Consumer Healthcare’s Theraflu to provide relief for those facing access barriers to sick time and raise awareness of the cultural stigma associated with taking a sick day.

PING Innovation Award recognizes individuals and organizations whose ideas, products, services or processes in life sciences sector are making a positive impact on people‘s lives.

AstraZeneca’s Niko Andre discusses the power of patient partnership in driving medical progress.

Analytic work will drive regulatory grade RWD studies and therapeutic evidence to improve patient outcomes.

Novo Nordisk announces plans to invest more than 17bn Danish kroner constructing three new manufacturing facilities in Kalundborg, Denmark.​

Pharma executives cite supply chain visibility as critical solution to alleviating product loss and security concerns, while one-third are dissatisfied with current solutions.

Workplace equality accelerating for healthcare industry’s Gender Parity Collaborative.

The White House nominates Robert Califf to once again take the reins of FDA, but acting commissioner Janet Woodcock will remain in place during the Senate confirmation process.

Merck and Ridgeback Biotherapeutics’ anti-viral pill is reported to halve the risk of hospitalization or death.

Solution leverages AI and natural language processing to accelerate and improve the review of materials used to market pharmaceutical and medical device products.

Carlyle and co-investors including Amgen Ventures, Merck Global Health Innovation Fund, Pfizer Ventures, and Population Health Partners to acquire majority stake in Saama Technologies.

Stay-at-home orders during the pandemic forced a shift in patient preferences—and the pharma industry has responded.

Rebrand launched to design, develop, and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries.

PharmaLex has announced the launch of a new service line, Biopharma Excellence, and appointed a new Chief Medical Officer.

With the headlines focused on COVID-19, many may have forgotten about the escalating epidemic of substance use disorder. National Recovery Month is a time to bring this issue back to the top of the agenda, raise awareness, and drive action, writes Richard Pops, CEO of Alkermes.